Home LiteratureArticle Details
PMID: 1733781 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Nitrendipine is a potent inhibitor of the Ca(2+)-activated K+ channel of human erythrocytes.

FEBS letters ·Vol. 296 ·No. 2 ·1992-01-20 ·Pages 219-21

Ellory JC, Kirk K, Culliford SJ, Nash GB, Stuart J

Abstract

Nitrendipine, a classical blocker of L-type Ca2+ channels, is shown to be a potent inhibitor of the Ca(2+)-activated K+ channel of human erythrocytes. In erythrocytes suspended in a solution with physiological Na+ and K+ concentrations and in which the channel was activated using the Ca2+ ionophore ionomycin, nitrendipine inhibited K+(86Rb+) influx with an I50 of around 130 nM. Similar results were obtained for K+(86Rb+) efflux, and for K+(86Rb+) influx into cells suspended in a high-K+ medium.

MeSH Terms
Calcium/pharmacology Dose-Response Relationship, Drug Erythrocytes/drug effects,metabolism Humans Nitrendipine/pharmacology Potassium Channels/drug effects,metabolism
Chemicals
Potassium Channels Nitrendipine Calcium
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ellory J C
University Laboratory of Physiology, University of Oxford, UK.
Kirk K
Culliford S J
Nash G B
Stuart J
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1992-01-20
Pages
219-21
Language
English
Region
England
NLM ID
0155157
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com